Log in

NASDAQ:EPIXESSA Pharma Stock Price, Forecast & News

$6.10
-0.08 (-1.29 %)
(As of 07/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$6.02
Now: $6.10
$6.18
50-Day Range
$4.81
MA: $5.55
$6.20
52-Week Range
$1.41
Now: $6.10
$6.29
Volume1,900 shs
Average Volume34,251 shs
Market Capitalization$127.03 million
P/E RatioN/A
Dividend YieldN/A
Beta1.73
ESSA Pharma Inc., a pharmaceutical company, focuses on the development of small molecule drugs for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.
Read More
ESSA Pharma logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.63 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:EPIX
CUSIPN/A
Phone778-331-0962

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$2.37 per share

Profitability

Net Income$-10,440,000.00

Miscellaneous

Employees15
Market Cap$127.03 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable

Receive EPIX News and Ratings via Email

Sign-up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter.

ESSA Pharma (NASDAQ:EPIX) Frequently Asked Questions

How has ESSA Pharma's stock been impacted by COVID-19 (Coronavirus)?

ESSA Pharma's stock was trading at $4.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, EPIX stock has increased by 49.9% and is now trading at $6.10. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of ESSA Pharma?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ESSA Pharma in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for ESSA Pharma.

When is ESSA Pharma's next earnings date?

ESSA Pharma is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for ESSA Pharma.

How were ESSA Pharma's earnings last quarter?

ESSA Pharma Inc (NASDAQ:EPIX) issued its quarterly earnings results on Thursday, May, 7th. The company reported ($0.45) EPS for the quarter, missing the Zacks' consensus estimate of ($0.22) by $0.23. View ESSA Pharma's earnings history.

What price target have analysts set for EPIX?

3 Wall Street analysts have issued 12 month price targets for ESSA Pharma's shares. Their forecasts range from $8.00 to $9.00. On average, they anticipate ESSA Pharma's share price to reach $8.50 in the next twelve months. This suggests a possible upside of 39.3% from the stock's current price. View analysts' price targets for ESSA Pharma.

Has ESSA Pharma been receiving favorable news coverage?

Media headlines about EPIX stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. ESSA Pharma earned a news sentiment score of 2.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the near term. View the latest news about ESSA Pharma.

Who are some of ESSA Pharma's key competitors?

What other stocks do shareholders of ESSA Pharma own?

Who are ESSA Pharma's key executives?

ESSA Pharma's management team includes the following people:
  • Dr. David Ross Parkinson, Pres, CEO & Director (Age 69)
  • Mr. David S. Wood, Chief Financial Officer (Age 62)
  • Mr. Peter A. Virsik, Exec. VP & COO (Age 48)
  • Dr. Raymond Andersen, CTO, Sec. & Director (Age 72)
  • Dr. Marianne D. Sadar, Chief Scientific Officer & Director (Age 58)

What is ESSA Pharma's stock symbol?

ESSA Pharma trades on the NASDAQ under the ticker symbol "EPIX."

How do I buy shares of ESSA Pharma?

Shares of EPIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ESSA Pharma's stock price today?

One share of EPIX stock can currently be purchased for approximately $6.10.

How big of a company is ESSA Pharma?

ESSA Pharma has a market capitalization of $127.03 million. The company earns $-10,440,000.00 in net income (profit) each year or ($1.46) on an earnings per share basis. ESSA Pharma employs 15 workers across the globe.

What is ESSA Pharma's official website?

The official website for ESSA Pharma is www.essapharma.com.

How can I contact ESSA Pharma?

ESSA Pharma's mailing address is 999 WEST BROADWAY SUITE 720, VANCOUVER A1, V5Z 1K5. The company can be reached via phone at 778-331-0962 or via email at [email protected]

This page was last updated on 7/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.